Published in Clin Nutr on May 07, 2010
The role of androgens and estrogens on healthy aging and longevity. J Gerontol A Biol Sci Med Sci (2012) 1.13
Translational studies in older men using testosterone to treat sarcopenia. Trans Am Clin Climatol Assoc (2014) 0.83
Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?! J Cachexia Sarcopenia Muscle (2011) 0.81
Supra-physiological doses of testosterone affect membrane oxidation of human neutrophils monitored by the fluorescent probe C₁₁-BODIPY⁵⁸¹/⁵⁹¹. Eur J Appl Physiol (2012) 0.81
Muscle changes in aging: understanding sarcopenia. Sports Health (2014) 0.80
Nutritionally essential amino acids and metabolic signaling in aging. Amino Acids (2012) 0.80
Androgen receptor polyglutamine repeat number: models of selection and disease susceptibility. Evol Appl (2012) 0.78
Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab (2001) 7.53
Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2006) 5.58
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med (1996) 4.10
Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci (2001) 2.42
The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab (2004) 2.34
Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab (2002) 2.24
Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab (2000) 2.17
Skeletal muscle apoptosis, sarcopenia and frailty at old age. Exp Gerontol (2006) 2.01
Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. J Clin Endocrinol Metab (2002) 1.96
Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab (1992) 1.94
The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. J Clin Endocrinol Metab (2005) 1.89
Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol (1995) 1.80
Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab (1997) 1.73
Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat Clin Pract Endocrinol Metab (2006) 1.63
Testosterone replacement in prostate cancer survivors with hypogonadal symptoms. BJU Int (2009) 1.60
Hypogonadism in elderly men--what to do until the evidence comes. N Engl J Med (2004) 1.57
Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J Immunol (1999) 1.50
Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci (2003) 1.48
Testosterone and growth hormone improve body composition and muscle performance in older men. J Clin Endocrinol Metab (2009) 1.40
Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril (2002) 1.35
Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J Immunol (2001) 1.34
Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men. J Clin Endocrinol Metab (2006) 1.31
Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab (2006) 1.30
Multiple hormonal deficiencies in anabolic hormones are found in frail older women: the Women's Health and Aging studies. J Gerontol A Biol Sci Med Sci (2009) 1.29
Higher muscle protein synthesis in women than men across the lifespan, and failure of androgen administration to amend age-related decrements. FASEB J (2008) 1.24
The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn. Ann Surg (2007) 1.20
Proof of the effect of testosterone on skeletal muscle. J Endocrinol (2001) 1.16
Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab (2009) 1.16
Skeletal muscle and bone: effect of sex steroids and aging. Adv Physiol Educ (2008) 1.13
Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men. J Am Geriatr Soc (2008) 1.13
Selective androgen receptor modulators in preclinical and clinical development. Nucl Recept Signal (2008) 1.11
The effects of gonadotropin treatment on the immunological features of male patients with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab (2000) 1.08
Continuous testosterone administration prevents skeletal muscle atrophy and enhances resistance to fatigue in orchidectomized male mice. Am J Physiol Endocrinol Metab (2006) 1.08
Impact of androgens, growth hormone, and IGF-I on bone and muscle in male mice during puberty. J Bone Miner Res (2007) 1.06
Measurement of myostatin concentrations in human serum: Circulating concentrations in young and older men and effects of testosterone administration. Mol Cell Endocrinol (2009) 1.03
An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate. Endocrinology (2006) 1.02
Testosterone protects against dexamethasone-induced muscle atrophy, protein degradation and MAFbx upregulation. J Steroid Biochem Mol Biol (2008) 1.01
Wide variability in laboratory reference values for serum testosterone. J Sex Med (2006) 1.01
Measures of bioavailable serum testosterone and estradiol and their relationships with muscle mass, muscle strength and bone mineral density in postmenopausal women: a cross-sectional study. Eur J Endocrinol (2009) 0.99
Testosterone, sex hormone-binding globulin and free androgen index among adult women: chronological and ovarian aging. Hum Reprod (2009) 0.99
Effect of testosterone and a nutritional supplement, alone and in combination, on hospital admissions in undernourished older men and women. Am J Clin Nutr (2009) 0.98
The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction. J Sex Med (2009) 0.96
Determinants of serum total and free testosterone levels in women over the age of 65 years. J Clin Endocrinol Metab (2006) 0.96
Androgen therapy induces muscle protein anabolism in older women. J Clin Endocrinol Metab (2006) 0.94
Testosterone supplementation for aging-associated sarcopenia. J Gerontol A Biol Sci Med Sci (2003) 0.93
Pharmacokinetics of a testosterone gel in healthy postmenopausal women. J Clin Endocrinol Metab (2005) 0.92
Regulation of signaling pathways downstream of IGF-I/insulin by androgen in skeletal muscle of glucocorticoid-treated rats. J Trauma (2009) 0.91
Androgens negatively regulate myostatin expression in an androgen-dependent skeletal muscle. Biochem Biophys Res Commun (2007) 0.89
Expression of the muscle atrophy factor muscle atrophy F-box is suppressed by testosterone. Endocrinology (2008) 0.89
Tissue selectivity of the anabolic steroid, 19-nor-4-androstenediol-3beta,17beta-diol in male Sprague Dawley rats: selective stimulation of muscle mass and bone mineral density relative to prostate mass. Endocrinology (2007) 0.88
Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals. Eur J Endocrinol (2009) 0.87
Modulation of overload-induced inflammation by aging and anabolic steroid administration. Exp Gerontol (2006) 0.86
Androgen deficiency in the aging male. Fertil Steril (2008) 0.86
Androgen deficiency: effects on body composition. Pituitary (2009) 0.85
Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas (2009) 0.84
The effects of growth hormone and/or testosterone on whole body protein kinetics and skeletal muscle gene expression in healthy elderly men: a randomized controlled trial. J Clin Endocrinol Metab (2008) 0.83
Androgen replacement therapy improves function in male rat muscles independently of hypertrophy and activation of the Akt/mTOR pathway. Acta Physiol (Oxf) (2008) 0.82
Effects of treatment with oxandrolone for 4 years on the frequency of severe arithmetic learning disability in girls with Turner syndrome. J Pediatr (2009) 0.82
The effect of short-term use of testosterone enanthate on muscular strength and power in healthy young men. J Strength Cond Res (2007) 0.82
Effects of age on testicular function and consequences of testosterone treatment. J Clin Endocrinol Metab (2001) 0.80
Study of adverse outcomes in women using testosterone therapy. Maturitas (2008) 0.79
Muscle-bound? A tissue-selective nonsteroidal androgen receptor modulator. Endocrinology (2007) 0.79
Safety of testosterone use in women. Maturitas (2009) 0.76
Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci (2005) 3.14
A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am J Physiol Endocrinol Metab (2006) 2.80
Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults. Am J Clin Nutr (2003) 2.65
Amino acid ingestion improves muscle protein synthesis in the young and elderly. Am J Physiol Endocrinol Metab (2003) 2.41
Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab (2002) 2.24
Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging. J Appl Physiol (1985) (2008) 2.20
Aging is associated with diminished accretion of muscle proteins after the ingestion of a small bolus of essential amino acids. Am J Clin Nutr (2005) 2.15
Management of blood glucose in type 2 diabetes mellitus. Am Fam Physician (2009) 2.09
Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Intern Med (2013) 2.05
Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse. FASEB J (2005) 1.97
A moderate serving of high-quality protein maximally stimulates skeletal muscle protein synthesis in young and elderly subjects. J Am Diet Assoc (2009) 1.70
Endocrine control of body composition in infancy, childhood, and puberty. Endocr Rev (2005) 1.67
Intramuscular and liver triglycerides are increased in the elderly. J Clin Endocrinol Metab (2004) 1.62
Novel noninvasive breath test method for screening individuals at risk for diabetes. Diabetes Care (2008) 1.57
Atrophy and impaired muscle protein synthesis during prolonged inactivity and stress. J Clin Endocrinol Metab (2006) 1.56
Differential stimulation of muscle protein synthesis in elderly humans following isocaloric ingestion of amino acids or whey protein. Exp Gerontol (2005) 1.53
Amino acid supplementation increases lean body mass, basal muscle protein synthesis, and insulin-like growth factor-I expression in older women. J Clin Endocrinol Metab (2009) 1.45
Essential amino acid and carbohydrate supplementation ameliorates muscle protein loss in humans during 28 days bedrest. J Clin Endocrinol Metab (2004) 1.43
Altered excitation-contraction coupling with skeletal muscle specific FKBP12 deficiency. FASEB J (2004) 1.24
Insulin stimulates human skeletal muscle protein synthesis via an indirect mechanism involving endothelial-dependent vasodilation and mammalian target of rapamycin complex 1 signaling. J Clin Endocrinol Metab (2010) 1.24
Inflammatory burden and amino acid metabolism in cancer cachexia. Curr Opin Clin Nutr Metab Care (2009) 1.17
Generation of reactive oxygen and nitrogen species in contracting skeletal muscle: potential impact on aging. Ann N Y Acad Sci (2002) 1.16
Differential anabolic effects of testosterone and amino acid feeding in older men. J Clin Endocrinol Metab (2003) 1.16
Pharmacological vasodilation improves insulin-stimulated muscle protein anabolism but not glucose utilization in older adults. Diabetes (2010) 1.13
Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men. J Clin Endocrinol Metab (2002) 1.13
The role of androgens and estrogens on healthy aging and longevity. J Gerontol A Biol Sci Med Sci (2012) 1.13
Exogenous amino acids stimulate human muscle anabolism without interfering with the response to mixed meal ingestion. Am J Physiol Endocrinol Metab (2004) 1.09
Age-related anabolic resistance after endurance-type exercise in healthy humans. FASEB J (2010) 1.09
Leucine supplementation chronically improves muscle protein synthesis in older adults consuming the RDA for protein. Clin Nutr (2012) 1.09
Effect of growth hormone replacement therapy on cognition after traumatic brain injury. J Neurotrauma (2010) 1.08
An overview of the endocrinology of skeletal muscle. Trends Endocrinol Metab (2004) 1.02
The catabolic effects of prolonged inactivity and acute hypercortisolemia are offset by dietary supplementation. J Clin Endocrinol Metab (2004) 1.01
Amino acid metabolism and inflammatory burden in ovarian cancer patients undergoing intense oncological therapy. Clin Nutr (2007) 0.98
The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men. J Gerontol A Biol Sci Med Sci (2012) 0.96
Method for the determination of the arteriovenous muscle protein balance during non-steady-state blood and muscle amino acid concentrations. Am J Physiol Endocrinol Metab (2005) 0.95
Androgen therapy induces muscle protein anabolism in older women. J Clin Endocrinol Metab (2006) 0.94
Plasma triglycerides are not related to tissue lipids and insulin sensitivity in elderly following PPAR-alpha agonist treatment. Mech Ageing Dev (2007) 0.92
Skeletal muscle protein anabolic response to increased energy and insulin is preserved in poorly controlled type 2 diabetes. J Nutr (2006) 0.91
Pathogenesis of muscle wasting in cancer cachexia: targeted anabolic and anticatabolic therapies. Curr Opin Clin Nutr Metab Care (2010) 0.89
Identification of ERK and JNK as signaling mediators on protein kinase C activation in cultured granulosa cells. Mol Cell Endocrinol (2008) 0.88
Effects of dietary curcumin or N-acetylcysteine on NF-kappaB activity and contractile performance in ambulatory and unloaded murine soleus. Nutr Metab (Lond) (2005) 0.87
Skeletal muscle is anabolically unresponsive to an amino acid infusion in pediatric burn patients 6 months postinjury. Ann Surg (2011) 0.87
Hypercortisolemia alters muscle protein anabolism following ingestion of essential amino acids. Am J Physiol Endocrinol Metab (2003) 0.87
A randomized pilot study of monthly cycled testosterone replacement or continuous testosterone replacement versus placebo in older men. J Clin Endocrinol Metab (2011) 0.87
Identification of serum biomarkers for aging and anabolic response. Immun Ageing (2011) 0.86
Muscle protein metabolism responds similarly to exogenous amino acids in healthy younger and older adults during NO-induced hyperemia. Am J Physiol Regul Integr Comp Physiol (2011) 0.85
Sildenafil increases muscle protein synthesis and reduces muscle fatigue. Clin Transl Sci (2013) 0.84
The use of DNA microarrays to assess clinical samples: the transition from bedside to bench to bedside. Recent Prog Horm Res (2003) 0.82
IGF-1 controls GLUT3 expression in muscle via the transcriptional factor Sp1. Biochim Biophys Acta (2007) 0.82
Effects of raloxifene on insulin sensitivity, beta-cell function, and hepatic insulin extraction in normal postmenopausal women. Fertil Steril (2007) 0.82
Cancer cachexia and anabolic interventions: a case report. J Cachexia Sarcopenia Muscle (2012) 0.80
Effect of recombinant growth hormone replacement in a growth hormone deficient subject recovering from mild traumatic brain injury: A case report. Brain Inj (2010) 0.80
Aerobic capacity and growth hormone deficiency after traumatic brain injury. J Clin Endocrinol Metab (2008) 0.79
Up-regulation of basal transcriptional activity of the cytochrome P450 cholesterol side-chain cleavage (CYP11A) gene by isoform-specific calcium-calmodulin-dependent protein kinase in primary cultures of ovarian granulosa cells. Endocrinology (2004) 0.79
What are critical outcome measures for patients receiving pituitary replacement following brain injury? Pituitary (2012) 0.78
Insulin-like growth factor-I activates extracellularly regulated kinase to regulate the p450 side-chain cleavage insulin-like response element in granulosa cells. Endocrinology (2010) 0.78
Neuropsychological and physiological correlates of fatigue following traumatic brain injury. Brain Inj (2014) 0.78
Serum IGF-1 concentrations in a sample of patients with traumatic brain injury as a diagnostic marker of growth hormone secretory response to glucagon stimulation testing. Clin Endocrinol (Oxf) (2011) 0.78
Sex steroid receptors in skeletal differentiation and epithelial neoplasia: is tissue-specific intervention possible? Bioessays (2009) 0.77
Isoproternenol increases vascular volume expansion and urinary output after a large crystalloid bolus in healthy volunteers. Shock (2014) 0.76
Expression of messenger ribonucleic acid encoding steroidogenic enzymes in postmenopausal ovaries. J Soc Gynecol Investig (2003) 0.76
Hormonal replacement in patients with brain injury-induced hypopituitarism: who, when and how to treat? Pituitary (2005) 0.76
Weekly versus monthly testosterone administration on fast and slow skeletal muscle fibers in older adult males. J Clin Endocrinol Metab (2014) 0.75
The relationships between testosterone, body composition, and insulin resistance: a lesson from a case of extreme hyperandrogenism. Diabetes Care (2005) 0.75
Critical issues for engineering cord blood stem cells to produce insulin. Expert Opin Biol Ther (2008) 0.75